Tune Therapeutics is a cutting-edge biotechnology company founded by world-class leaders in epigenome editing. Tune strives to develop paradigm-changing cell and gene therapies that leverage epigenetic programming for the treatment of devastating diseases. Join a highly skilled and dynamic team with expertise that spans basic discovery all the way to clinical implementation. We are passionate about the technology and its potential to help patients in need.